IE
CNTB

Israel Englander’s Connect Biopharma Holdings CNTB Stock Holding History

Israel Englander’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
43,708
-430,893
-91% -$1.04M ﹤0.01% 5491
2026
Q1 		$1.24M Buy
474,601
+427,551
+909% +$1.11M ﹤0.01% 4225
2025
Q4 		$133K Buy
+47,050
New +$100K ﹤0.01% 5579
2021
Q3 		– Sell
-42,856
Closed -$837K – 6833
2021
Q2 		$837K Buy
42,856
+31,757
+286% +$530K ﹤0.01% 4833
2021
Q1 		$205K Buy
+11,099
New +$189K ﹤0.01% 5482

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Israel Englander's CNTB Position: Q2 2026 in Review

Israel Englander reduced its Connect Biopharma Holdings (CNTB) stake by 91% in Q2 2026, selling an estimated $1.04M and leaving 43,708 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #5491.

Israel Englander first reported a position in CNTB in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.24M in Q1 2026. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Israel Englander held 43,708 shares of Connect Biopharma Holdings worth $104K as of Q2 2026.
  • Israel Englander sold 430,893 Connect Biopharma Holdings shares in Q2 2026, an estimated $1.04M.
  • Connect Biopharma Holdings made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5491 holding.
  • Israel Englander first reported a position in Connect Biopharma Holdings in Q1 2021 and has held it in 5 quarters since.
  • Israel Englander's Connect Biopharma Holdings position peaked at $1.24M in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.